Full text
PDFPage 632

Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Altman R. D., Johnston C. C., Khairi M. R., Wellman H., Serafini A. N., Sankey R. R. Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans). N Engl J Med. 1973 Dec 27;289(26):1379–1384. doi: 10.1056/NEJM197312272892601. [DOI] [PubMed] [Google Scholar]
- DeRose J., Singer F. R., Avramides A., Flores A., Dziadiw R., Baker R. K., Wallach S. Response of Paget's disease to porcine and salmon calcitonins: effects of long-term treatment. Am J Med. 1974 Jun;56(6):858–866. doi: 10.1016/0002-9343(74)90815-8. [DOI] [PubMed] [Google Scholar]
- Ryan W. G., Schwartz T. B., Perlia C. P. Effects of mithramycin on Paget's disease of bone. Ann Intern Med. 1969 Mar;70(3):549–557. doi: 10.7326/0003-4819-70-3-549. [DOI] [PubMed] [Google Scholar]
- WOODARD H. Q. Long term studies of the blood chemistry in Paget's disease of bone. Cancer. 1959 Nov-Dec;12:1226–1237. doi: 10.1002/1097-0142(195911/12)12:6<1226::aid-cncr2820120617>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
- Woodhouse N. J., Bordier P., Fisher M., Joplin G. F., Reiner M., Kalu D. N., Foster G. V., MacIntyre I. Human calcitonin in the treatment of Paget's bone disease. Lancet. 1971 Jun 5;1(7710):1139–1143. doi: 10.1016/s0140-6736(71)91657-6. [DOI] [PubMed] [Google Scholar]
